Absolute numbers of cells after treatment with daclizumab.

Note the difference in scale of the y-axis between graphs. (A) Absolute number of lymphocytes (ALC) (solid line), CD3⁺56⁻ (dashed line) and CD3 ⁻ 56⁺(dotted line) cells after treatment with daclizumab. (B) Absolute number of CD3⁺56⁻ cells (solid line), CD3⁺DR⁺ cells (dashed line), CD3⁺7G7⁺ cells (dotted line), and CD3⁺25⁺ cells (thin line) after treatment with daclizumab.